Eye Banking: History and Future Direction

  • Sudarshan SrivatsanEmail author
  • Shahzad I. Mian


This chapter explores the history of eye banking, from the first corneal transplant performed by Dr. Eduard Zirm to innovative advancements in the field. The growth of eye banking can be traced to regulations surrounding organ harvesting for transplantation and standardization of eye banking protocols via the Eye Bank Association of America. Additionally, the role of eye banks has evolved significantly through the development of lamellar keratoplasty including DMEK and DSAEK, which has also contributed to the surge in corneal transplantation. In this chapter, we discuss the evolving landscape of eye banking, along with changes in how grafts are prepared for transplantation. This chapter also discusses the future of eye banking, including how new technologies such as engineered grafts and injectable corneal endothelial cells may further change eye banks and their role in processing of tissue for corneal transplantation.


Cornea Corneal transplantation Eye bank DSAEK DMEK EBAA 


  1. 1.
    Crawford AZ, Patel DV, McGhee CN. A brief history of corneal transplantation: from ancient to modern. Oman J Ophthalmol. 2013;6(Suppl 1):S12–7. Scholar
  2. 2.
    Farge EJ. Eye banking: 1944 to the present. Surv Ophthalmol. 1989;33(4):260–3.CrossRefPubMedGoogle Scholar
  3. 3.
  4. 4.
    EBAA statistical report, 2017.Google Scholar
  5. 5.
    Verheijde JL, Rady MY, McGregor JL. The United States Revised Uniform Anatomical Gift Act (2006): new challenges to balancing patient rights and physician responsibilities. Philos Ethics Humanit Med. 2007;2:19. Scholar
  6. 6.
    Aiken-O’Neill P, Mannis MJ. The evolution of eye banking in the United States: landmarks in the history of the Eye Bank Association of America. Int J Eye Bank. 2012;1(1)Google Scholar
  7. 7.
  8. 8.
    Pineda R. Corneal transplantation in the developing world: lessons learned and meeting the challenge. Cornea. 2015;34(Suppl 10):S35–40. Scholar
  9. 9.
  10. 10.
    EBAA Medical Standards, 2019.Google Scholar
  11. 11.
    Site Inspection Questionnaire.Google Scholar
  12. 12.
  13. 13.
    The effect of donor age on corneal transplantation outcome: results of the cornea donor study. Ophthalmology. 2008;115(4):620–626.e6. Scholar
  14. 14.
    Rosenwasser GO, Szczotka-Flynn LB, Ayala AR, et al. Effect of cornea preservation time on success of Descemet stripping automated endothelial keratoplasty: a randomized clinical trial. JAMA Ophthalmol. 2017;135(12):1401–9. Scholar
  15. 15.
    Lass J, Benetz BA, Verdier DD, et al. Corneal endothelial cell loss 3 years after successful Descemet stripping automated endothelial keratoplasty in the cornea preservation time study: a randomized clinical trial. JAMA Ophthalmol. 2017;135(12):1394–400. Scholar
  16. 16.
  17. 17.
    Boynton GE, Woodward MA. Eye-bank preparation of endothelial tissue. Curr Opin Ophthalmol. 2014;25(4):319–24. Scholar
  18. 18.
    Tourtas T, Laaser K, Bachmann BO, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty versus descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012;153(6):1082–1090.e2. Scholar
  19. 19.
    Lie JT, Birbal R, Ham L, van der Wees J, Melles GRJ. Donor tissue preparation for Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2008;34(9):1578–83. Scholar
  20. 20.
    Melles GRJ, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25(8):987–90. Scholar
  21. 21.
    Price MO, Giebel AW, Fairchild KM, Price FW. Descemet’s membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116(12):2361–8. Scholar
  22. 22.
    Anwar M, Teichmann KD. Big-bubble technique to bare Descemet’s membrane in anterior lamellar keratoplasty. J Cataract Refract Surg. 2002;28(3):398–403.CrossRefPubMedGoogle Scholar
  23. 23.
    Zeidenweber DA, Tran KD, Sales CS, Wehrer SW, Straiko MD, Terry MA. Prestained and preloaded DMEK grafts: an evaluation of tissue quality and stain retention. Cornea. 2017;36(11):1402–7. Scholar
  24. 24.
    Tran KD, Dye PK, Odell K, et al. Evaluation and quality assessment of prestripped, preloaded Descemet membrane endothelial keratoplasty grafts. Cornea. 2017;36(4):484–90. Scholar
  25. 25.
    Parekh M, Ruzza A, Ferrari S, Busin M, Ponzin D. Preloaded tissues for Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2016;166:120–5. Scholar
  26. 26.
    Busin M, Leon P, D’Angelo S, et al. Clinical outcomes of preloaded Descemet membrane endothelial keratoplasty grafts with endothelium tri-folded inwards. Am J Ophthalmol. 2018;193:106–13. Scholar
  27. 27.
    Global survey of corneal transplantation and eye banking.Google Scholar
  28. 28.
    Lambert NG, Chamberlain WD. The structure and evolution of eye banking: a review on eye banks’ historical, present, and future contribution to corneal transplantation. J Biorepository Sci Appl Med. 5:23.
  29. 29.
    Griffith M, Jackson WB, Lagali N, Merrett K, Li F, Fagerholm P. Artificial corneas: a regenerative medicine approach. Eye (Lond). 2009;23(10):1985–9. Scholar
  30. 30.
    Blake DA, Yu H, Young DL, Caldwell DR. Matrix stimulates the proliferation of human corneal endothelial cells in culture. Invest Ophthalmol Vis Sci. 1997;38(6):1119–29.PubMedGoogle Scholar
  31. 31.
    Wilson SE, Lloyd SA, He YG, McCash CS. Extended life of human corneal endothelial cells transfected with the SV40 large T antigen. Invest Ophthalmol Vis Sci. 1993;34(6):2112–23.PubMedGoogle Scholar
  32. 32.
    Zhu C, Joyce NC. Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci. 2004;45(6):1743–51.CrossRefGoogle Scholar
  33. 33.
    Joyce NC, Harris DL, Mello DM. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Invest Ophthalmol Vis Sci. 2002;43(7):2152–9.PubMedGoogle Scholar
  34. 34.
    He Z, Campolmi N, Gain P, et al. Revisited microanatomy of the corneal endothelial periphery: new evidence for continuous centripetal migration of endothelial cells in humans. Stem Cells. 2012;30(11):2523–34. Scholar
  35. 35.
    Mimura T, Shimomura N, Usui T, et al. Magnetic attraction of iron-endocytosed corneal endothelial cells to Descemet’s membrane. Exp Eye Res. 2003;76(6):745–51.CrossRefGoogle Scholar
  36. 36.
    Mimura T, Yamagami S, Usui T, et al. Long-term outcome of iron-endocytosing cultured corneal endothelial cell transplantation with magnetic attraction. Exp Eye Res. 2005;80(2):149–57. Scholar
  37. 37.
    Okumura N, Fujii K, Kagami T, et al. Activation of the rho/rho kinase signaling pathway is involved in cell death of corneal endothelium. Invest Ophthalmol Vis Sci. 2016;57(15):6843–51. Scholar
  38. 38.
    Okumura N, Sakamoto Y, Fujii K, et al. Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction. Sci Rep. 2016;6:26113. Scholar
  39. 39.
    Kinoshita S, Koizumi N, Ueno M, et al. Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378(11):995–1003. Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.University of Michigan Medical SchoolAnn ArborUSA
  2. 2.University of Michigan/Kellogg Eye Center, Ophthalmology and Visual SciencesAnn ArborUSA

Personalised recommendations